Peraso Inc. (PRSO): Nasdaq/NYSE listing notice — Peraso receives Nasdaq deficiency notice for minimum bid price non-compliance

Peraso Inc.

Nasdaq letter on Sept 5, 2025: closing bid price below $1 for 30 consecutive business days ended Sept 4, 2025.
Company has 180 calendar days, until March 4, 2026, to regain compliance.
To regain compliance, closing bid price must be at least $1 for a minimum of 10 consecutive business days.
If not cured, Company may seek a second 180-day compliance period if it meets other listing standards and intends to effect a reverse stock split.
No immediate delisting; Company is monitoring bid price and evaluating options.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Peraso Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

September 5, 2025, Peraso Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock (“Common Stock”) for the 30 consecutive business days ending on September 4, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until March 4, 2026, in which to

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Peraso Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-085117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.